Skip to content

Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate

C34H43F3N6O4S — CID 154945036

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate
SMILESCCc1cc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1O[C@H](C)CN1C[C@@H](C)N(C(=O)OC(C)(C)C)[C@H](C)C1
InChIInChI=1S/C34H43F3N6O4S/c1-10-23-13-24(43-30(48)42(29(44)33(43,8)9)25-14-26(34(35,36)37)27(15-38)39-16-25)11-12-28(23)46-22(4)19-40-17-20(2)41(21(3)18-40)31(45)47-32(5,6)7/h11-14,16,20-22H,10,17-19H2,1-9H3/t20-,21-,22-/m1/s1
InChIKeyITZBMYGHIWGBFO-YPAWHYETSA-N
MW688.82 g/mol
LogP6.55
Rot. Bonds7

About Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate

Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate (PubChem CID 154945036) has the molecular formula C34H43F3N6O4S and a molecular weight of 688.82 g/mol. Its IUPAC name is tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate.

Molecular Properties

Compound NameTert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate
PubChem CID154945036
Molecular FormulaC34H43F3N6O4S
Molecular Weight688.82 g/mol
Exact Mass688.30
IUPAC Nametert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate
SMILESCCc1cc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1O[C@H](C)CN1C[C@@H](C)N(C(=O)OC(C)(C)C)[C@H](C)C1
InChIInChI=1S/C34H43F3N6O4S/c1-10-23-13-24(43-30(48)42(29(44)33(43,8)9)25-14-26(34(35,36)37)27(15-38)39-16-25)11-12-28(23)46-22(4)19-40-17-20(2)41(21(3)18-40)31(45)47-32(5,6)7/h11-14,16,20-22H,10,17-19H2,1-9H3/t20-,21-,22-/m1/s1
InChIKeyITZBMYGHIWGBFO-YPAWHYETSA-N
XLogP6.55
TPSA102.24 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms48
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500688.82
LogP ≤ 56.55
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate?
The IUPAC name of Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate (CID 154945036) is tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate.
What is the SMILES notation for Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate?
The canonical SMILES for Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate is CCc1cc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1O[C@H](C)CN1C[C@@H](C)N(C(=O)OC(C)(C)C)[C@H](C)C1.
What is the InChIKey of Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate?
The InChIKey is ITZBMYGHIWGBFO-YPAWHYETSA-N. The full InChI is InChI=1S/C34H43F3N6O4S/c1-10-23-13-24(43-30(48)42(29(44)33(43,8)9)25-14-26(34(35,36)37)27(15-38)39-16-25)11-12-28(23)46-22(4)19-40-17-20(2)41(21(3)18-40)31(45)47-32(5,6)7/h11-14,16,20-22H,10,17-19H2,1-9H3/t20-,21-,22-/m1/s1.
What are the key properties of Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate?
Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate has a molecular weight of 688.82 g/mol, XLogP of 6.55, 7 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl (2R,6R)-4-[(2R)-2-[4-[3-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]propyl]-2,6-dimethylpiperazine-1-carboxylate is sourced from PubChem (CID 154945036), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.